Researchers have developed a new digital health tool that can help identify cancer patients who are at higher risk of developing serious bowel-related side effects from immunotherapy treatments.
The system uses clinical data and advanced analytics to assess patient risk before or during treatment, allowing doctors to better monitor vulnerable individuals. Immunotherapy, which helps the body’s immune system fight cancer, can sometimes trigger inflammation in the intestines, leading to severe complications in a small number of patients.
According to researchers, early detection of risk could help doctors adjust treatment plans, improve patient safety, and reduce hospitalizations caused by immune-related side effects.
Experts believe this technology represents an important step toward more personalized cancer care, where treatments are tailored not only to the type of cancer but also to how each patient is likely to respond.
The tool is currently being tested in clinical settings, and researchers hope it will eventually be integrated into routine cancer care to improve outcomes and reduce treatment risks.
